14-day Premium Trial Subscription Try For FreeTry Free
$0.700
-0.0149 (-2.08%)
At Close: Apr 25, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.619 $0.83 Thursday, 25th Apr 2024 ATRA stock ended at $0.700. This is 2.08% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 9.09% from a day low at $0.660 to a day high of $0.720.
90 days $0.570 $1.58
52 weeks $0.199 $3.02

Historical Atara Biotherapeutics prices

Date Open High Low Close Volume
May 03, 2021 $14.11 $14.36 $14.01 $14.05 433 865
Apr 30, 2021 $14.32 $14.57 $14.01 $14.06 448 199
Apr 29, 2021 $14.41 $14.91 $14.15 $14.53 817 256
Apr 28, 2021 $14.53 $14.66 $14.20 $14.34 1 025 577
Apr 27, 2021 $14.59 $14.95 $14.36 $14.65 549 846
Apr 26, 2021 $14.15 $14.63 $14.15 $14.49 1 564 943
Apr 23, 2021 $14.33 $14.62 $14.10 $14.14 455 245
Apr 22, 2021 $13.59 $14.50 $13.50 $14.31 630 368
Apr 21, 2021 $13.19 $13.72 $12.84 $13.64 595 371
Apr 20, 2021 $13.22 $13.53 $12.97 $13.29 2 951 876
Apr 19, 2021 $13.20 $13.49 $13.05 $13.30 822 681
Apr 16, 2021 $13.93 $13.93 $13.14 $13.28 629 675
Apr 15, 2021 $13.92 $14.19 $13.59 $13.94 1 073 585
Apr 14, 2021 $13.93 $14.36 $13.80 $13.85 459 593
Apr 13, 2021 $13.74 $13.91 $13.50 $13.90 428 576
Apr 12, 2021 $13.75 $14.00 $13.29 $13.70 627 823
Apr 09, 2021 $14.28 $14.28 $13.48 $13.77 647 460
Apr 08, 2021 $14.32 $14.55 $14.02 $14.19 517 695
Apr 07, 2021 $14.14 $14.57 $13.98 $14.20 1 097 011
Apr 06, 2021 $14.74 $14.74 $13.98 $14.15 727 898
Apr 05, 2021 $15.01 $15.21 $14.46 $14.66 727 955
Apr 01, 2021 $14.54 $15.13 $14.32 $14.91 944 843
Mar 31, 2021 $14.15 $14.63 $14.00 $14.36 872 873
Mar 30, 2021 $13.89 $14.45 $13.47 $14.22 665 493
Mar 29, 2021 $14.58 $14.79 $13.94 $14.00 722 797
Click to get the best stock tips daily for free!

About Atara Biotherapeutics

Atara Biotherapeutics Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i... ATRA Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 11.73% $52.28
LPLA Apr 19 1.08% $262.59
DOOR Apr 18 0.274% $131.39
LNG Apr 17 1.63% $156.81
FCN Apr 16 3.70% $207.62
ELV Apr 16 6.45% $506.97
AKR Apr 05 5.14% $16.53
ITCI Apr 05 5.39% $68.44
SARK Mar 28 14.47% $26.88
ARCC Mar 25 2.53% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT